Dal bambino linfatico al bambino con infezioni respiratorie ricorrenti

Definizioni ed epidemiologia
1. Janeway CA. The child with recurrent intections. Postgrad Med 1971;49:158.
2. Fior R, Panizon F. Il bambino catarrale. Prospettive in Pediatria 1975;18:253.
3. Stranger K. Respiratory illness in preschool children with different form of day care. Pediatrics 1976;57:191.
4. Paul ME, Shearer WT. The child with recurrent infections. Ped Allergy Immunol 1999; 19:423.
5. Ronchetti R, Mastella G, Battistini A, et al. Approccio epidemiologico alle malattie respiratorie croniche e recidivanti del bambino. Indagine policentrica. Prospettive in Pediatria 1978;29:9.
6. De Martino M, Vierucci A, Appendino C, et al. Il bambino con infezioni ricorrenti. Immunol Pediatr 1981;1:76.
7. De Martino M, Veneruso G, Vierucci A. Identikit del bambino che si ammala spesso. Medico e Bambino 1984;8:506.
8. Vierucci A, De Martino M, Galli L, et al. Aspetti diagnostici del bambino con infezioni respiratorie ricorrenti (IRR). Riv Inf Ped 1989; 1 (suppl):83. Tonsillite ricorrente e PFAPA
9. Marshall GS, Edwards KM, Butler J, Lewton AR. Syndrome of Periodic Fever, Pharyngitis, and Aphthous Stomatitis. Pediatr Infect Dis J 1987;110:43.
10. Padeh S, Breznik N, Zenner D, et al. Periodic fever, aphthous stomatitis, pharyngitis and adenopathy syndrome. J Pediatr 1999; 135:98.
11. Sprinkle PM, Veltri RW. Recurrent adenotonsillitis: a new concept. Laryngoscope 1976;86:58.
12. Yamanaka N, Kataura A. Viral infections associated with recurrent tonsillitis. Acta Otorinolaryngol 1984;416:30.
13. Mitani T, Tomoda K, Maeda N, et al. The tonsillar immune system and its response to exogenous antigens Acta Otorinolaryngol 1990;475:1.
14. Ramirez A, Perdrola D, Lopez, et al. Betahemolytic streptococci in tonsil hypertrophy and recurrent tonsillitis. Enferm Infect Microbiol Clin 1987;15:315.
15. Oesterland A, Pope R, Nikkilae T, et al. Intracellular reservoir of Streptococcus pyogenes in vivo: possible explanation for recurrent tonsillopharyngitis. Laryngoscope 1997;107: 640.
16. Lekston Hines JA, Dale JK, Kinguna DW, et al. Periodic illness associated with Epstein virus infection. Clin Infect Dis J 1996;81:141.
17. Mendoza A, Panizon F. Le tonsilliti ricorrenti da Adenovirus. Medico e Bambino 1998;17:378.
18. Dagaro P, Panizon F, Ventura A, Zocconi E. La tonsillite ricorrente e la tonsillite focale: una rivisitazione. Medico e Bambino 2001; 20:231.
19. De Miguel, Martinez I, Ramos Macias A, et al. Therapeutic possibilities in recurrent infantile tonsillitis. Acta Otorinolaryngol 1997; 107:640.
20. Baglio G, Bellussi I, Calia V, et al. Appropriatezza clinica e organizzativa degli interventi di tonsillectomia e adenotonsillectomia. Medico e Bambino 2003;22:441.
21. Olympia RP, Khine H, Avner JR. Effectiveness of oral dexamethasone in the treatment of moderate to severe pharyngitis in children. Arch Pediatr Adolesc Med 2005;115:280. Sinusite
22. Barbi E, Longo G. La sinusite. Medico e Bambino 2001;20:612.
23. Battistini A, Marvasi R. I disturbi respiratori ostruttivi nel sonno. Medico e Bambino 2005;24:652.
24. Campanello SG, Asher MI. Current controversies: sinus diseases and the lower airways. Pediat Pulmon 2001;31:165.
25. Yimenez G, Varan B, Yilmenez T, Gurakan B. Intranasal budesonide spray as an adjuvant to oral antibiotic therapy for acute sinusitis in children. Eur Arch Otorynolaryngol 2000;257:256.
26. Brouillette RT, Manoukian JJ, Gillman E, et al. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr 2001;138:838.
27. Cistulli PA, Palmisano RG, Poole MD. Treatment of obstructive sleep apnea syndrome by rapid maxillary expansion. Sleep 1998;15:21. Otite e laringospasmo ricorrenti
28. Niemela M, Pihakari O, Pokka T, Uhari M. Pacifier as risk factor for acute otitis media: a randomized controlled trial of parental counselling. Pediatrics 2000;106:483.
29. Behle R, Gruber WC. Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatr Infect Dis J 2000;19:S66.
30. Escola J, Kilpi T. Potential of vaccines in the prevention of acute otitis media. Paediatr Infect Dis J 2000;19:399.
31. Bronwer CN, Maille AR, Rovers MN, et al. Effect of pneumococcal vaccination on quality of life in children with recurrent otitis media. A randomized controlled study. Pediatrics 2005;115:273.
32. Streetman T. Pneumococcal 23-valent vaccine Cochrane database Syst Rev 2002 CD001480.
33. Canciani M, Longo G. Novità nella terapia del croup. Medico e Bambino 1995;14: 128.
34. Russell K, Wiebe N, Saenz A, et al. Glucocorticoids for croup. Cochrane Database Syst Rev 2004;(1):CD001955.
35. Bjornson CL, Klassen TP, Williamson J, et al. A randomized trial of a single dose of oral dexamethasone for mild croup. N Engl J Med 2004;351(13):1306.
36. Marchetti F, Longo G, Ventura A. Oral dexamethasone for mild croup. N Engl J Med 2004;351(26):2768. Tosse
37. Longo G, Barbi E. La tosse (e le tossi). Medico e Bambino 2000;19:631.
38. Chang AB. Isolated cough: probably not asthma. Arch Dis Child 1999;80:211.
39. Millqwist E. Cough provocation with capsaicine as an objective way to test sensory hyperreactivity with asthma-like symptoms. Allergy 2000;55:546.
40. Chang AB, Gibson PG. Relationship between cough, cough receptor sensitivity and asthma in children. Pulm Pharmacol Ther 2002;15(3):287. Immunologia
41. Lepore L, Longo F, Panizon F. Il bambino con infezioni respiratorie ricorrenti. Medico e Bambino 1985;5:626.
42. Beard LJ, Maxwell GM, Thong HY. Immunocompetency of children with frequent respiratory infections. Arch Dis Child 1981;56: 101.
43. De Martino M, Rossi ME, Muccioli T, Vierucci A. T lymphocytes in children with recurrent infections: effect of the use of thymostimuline on the alteration of T cells subsets. Infect J Tiss React 1984;6:223.
44. De Martino M, Cosenza Biagnoli E, Novembre E, et al. I linfociti T in corso di infezioni respiratorie ricorrenti. Riv Ital Ped 1979; 5:361.
45. Vierucci A, Bertotto A, De Martino M, et al. Le infezioni ricorrenti nel bambino: definizione e approccio diagnostico. Raccomandazioni proposte dal Gruppo di studio della SIP. Riv Immunol Allerg Pediatr 1988;2:123.
46. Hakansson L, Foucard T, Hallgren R, et al. Neutrophyl function in infection-prone children. Arch Dis Child 1981;56:776.
47. Lepore L, Longo F, Presani G, Panizon F. Il profilo immunologico del bambino con infezioni respiratorie ricorrenti. Riv Ital Ped 1984; 10:38.
48. Kelly CF, Mounino DM, Homa DM, et al. Asthma Phenotypes; risk factors and measures of severity in a national sample. Pediatrics 2005;115:726.
49. Heaton TJ, Rowe J, Turner S, et al. An immuno- epidemiologic approach to asthma. Identification of in vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet 2005;365:142.
50. Schroeder NW, Schumann RR. Single nucleotide polymorphism in Toll-like receptors and susceptibility to infectious diseases. Lancet Infect Dis 2005;5:156. Indicazioni terapeutiche generali
51. Weiss ST, Tager IB, Speizer FE. Passive smoking. Its relation to respiratory symptoms, pulmonary function and non-specific bronchial responsiveness. Chest 1983;84;651.
52. Bland M, Bewley BR, Pollard V, Bamks MH. Effect of children’s and parent’s smoking on respiratory symptoms. Arch Dis Child 1978;53:100.
53. Marchetti F, Ronfani L, Conti Nibali S, Tamburlini G, and Italian Study Group on Acute Otitis Media. Delayed prescription may reduce the use of antibiotics for acute otitis media: a prospective observational study in primary care. Arch Pediatr Adolesc Med 2005;159(7):679.
54. Ronfani L, Buzzetti R. Efficacia dei farmaci immunostimolanti nella prevenzione delle infezioni ricorrenti in età pediatrica. Da: Ugazio AG, Cavagni G. Il bambino con infezioni ricorrenti. Milano, Masson Ed., 2003.
55. Van Eygen M, Dils F, Gillerot J, Verschueren E. A double-blind pediatric evaluation of levamisole in the prevention of recurrent upper respiratory tract infections. Eur J Pediatr 1979;131:147.
56. Van Eygen M, Znamensky PY, Heck E, Raymaekers I. Levamisole in preventing respiratory tract infections in children. Lancet 1976;21:382-5.
57. Litzman J, Lokaj J, Krejci M, et al. Isoprinosine does not protect against frequent respiratory tract infections in children. Eur J Pediatr 1999;158:32.
58. Rutishauser M, Pitzke P, Grevers G, et al. Use of a polyvalent bacterial lysate in patients with recurrent respiratory tract infections in children: results of a prospective, placebocontrolled, randomized double blind study. Adv Ther 1998;15:330.
59. Riedl-Seifert RJ, van Aubel A, Kammereit A, Elsasser U. Reduction of the number and severity of respiratory tract infections in children by oral immunostimulation. Adv Exp Med Biol 1995;371B:799-802.
60. Caramia G, Clemente E, Solli R, et al. Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children. Arzneimittelforschung 1994;44(12A): 1480.
61. Careddu P, Mei V, Venturoli V, Corsini A. Pidotimod in the treatment of recurrent respiratory infections in children. Arzneimittelforschung 1994;44(12A):1485-9.
62. Burgio GR, Marseglia GL, Severi F, et al. Immunoactivation by pidotimod in children. Arzneimittelforschung 1994;44(12A):1525.
63. Motta G, de Campora E, De Vita C, et al. Immunoactivity of pidotimod against episodes of recurrent tonsillitis in children. Arzneimittelforschung 1994;44(12A):1521.
64. Careddu P. Role of immunoactivation with pidotimod in recurrent respiratory infections in children. Arzneimittelforschung 1994;44 (12A):1506.
65. Passali D, Calearo C, Conticello S. Pidotimod in the management of recurrent pharyngotonsillar infections in children. Arzneimittelforschung 1994;44(12A):1511.
66. Gutierrez-Tarango MD, Berber A. Safety and efficacy of two courses of OM-85. Chest 2001;119:1742.
67. Jara-Perez JV, Berber A. Primary prevention of acute respiratory infections in children using a bacterial immunostimulant: a doublemasked, placebo controlled clinical trial. Clin Ther 2000;22:748.
68. Collet JP, Ducruet T, Kramer MS, et al. Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. Pediatr infect Dis 1993;12:648.
69. Paupe J. Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections Respiration 1991;58:150.
70. Aivazis V, Hatzimichail A, Papachristou A, Valeri R, Iuga-Donca G. Clinical evaluation and changes in the respiratory epitelium function after administration of pidotimod in greek children with recurrent respiratory tract infections. Minerva Pediatr 2002;54:315.
71. La Mantia I, Grillo C, Mattina T, et al. Prophylaxis with the novel immunostimulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down’s syndrome. J Chemother 1999;11;126.
72. Vargas Correa JB, Espinosa Morales S, Bolanos Ancona JC, Farfan Ale JA. Pidotimod in recurrent respiratory infections in children with allergic rhinitis, asthma, or both conditions. Rev Allerg Mex 2002;49:27.
73. de la Torre Gonzalez C. Pacheco Rios A, Escalante Dominguez A, del Rio Navarro BE. Meta-analysis of immunoestimulant agents used in pediatric patients in Mexico. Rev Alerg Mex 2005;52:25.
74. del Rio-Navarro BE, Luis Sienra-Monge JJ, Berber A, et al. Use of OM-85BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclasses levels. Allergol Immunopathol 2003;31:7.
75. Schaad UB, Mutterlein R, Goffin H. BVstudy group. Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double blind, placebocontrolled multicenter study. Chest 2002; 122:2042.
76. Carmona-Ramirez MA, Alvarez-Gomez V, Berber A. Use of OM-85 BV for the prevention of acute respiratory tract infections in occupational medicine. J Int Med Res 2002; 30:325.
77. Berber A, Del Rio-Novarro BE. Compilation and meta-analysis of randomized placebo- controlled clinical trials on the prevention of respiratory tract infections in children using immunostimulants. J Investig allergol Clin Immunol 2001;11:235.
78. Alyanakian MA, Grela F, Aumeunier A, et al. Transforming Growth Factor (beta) and natural killer T-cells are involoved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes 2006;55:179.
79. Tamburlini G, Candusso M, Tozzi AE, Greco L (a cura di). Studio Italiano Infezioni Respiratorie Ricorrenti in Pediatria (SIRRP). Medico e Bambino 1988;10:625.
80. Fisher A. Faut-il vraiment utiliser les immunostimulants en pratique pédiatrique? Arch Pediatr 1999;6(2):427. 81 Notarangelo LD, Soresina A, Schumacher RF. Infezioni ricorrenti: tra evidenze cliniche e incertezze. Congresso Italiana di Pediatria
2004. Quaderni di Pediatria 2004;3:11.
82. Cohen HA, Varsoud I, Kahen E, et al. Effectiveness of an herbal preparation contining echinacea, propolis, and vitamin C in preventing respiratory tract infections in children. A randomized double-blind placebo-controlled, multicentric study. Arch Pediatr Adolesc Med 2004;158:222.
83. Sangvai S, Chianese J, Mozone N, Bogen DL, Voigt L, Shaikh N. Can an herbal preparation of echinacea, propolis, and vitamin C reduce respiratory illness in children? Arch Pediatr Adolesc Med 2004;158:222.
84. Strabd A, Chandyon RK, Hou J, et al. Effectiveness and efficacy of zinc for the treatment of acute diarrhea in young children. Pediatrics 2002;109:898.
85. Sazawal S, Black RE, Menon VP, et al. Zinc supplementation in infants born small for gestationl age reduces mortality: a prospective, randomized, controlled trial. Pediatrics 2001;108:1280.
86. Sazaval S, Black RG, Jalla S, et al. Zinc implementation reduces the incidence of acute lower respiratory infections in infants and preschool children. A double blind controlled trial. Pediatrics 1998:102:1.
87. Hattakka K, Korpela R, Meurman L, et al. Lactobacillus GG reduces infections in children attending day-care centers. Congresso Mondiale di Pediatria e Gastroenterologia, Boston 2000.
88. de Lange de Klerk ES, Blommers J, Kuik DJ, Bezemer PD, Feenstra L. Effect of homeopatic medicines on daily burden of symptoms in children with recurrent respiratory tract infections. BMJ 1994;309:1329.
89. Rovers MM, Schilder AG, Zielhuis RM. Otitis media. Lancet 2004;363(9407):465.
90. Cunnigham AF, Johns SL, Julious SA, et al. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Resp J 1988;11:345.
91. Esposito S, Blasi F, Arosio C, et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur Resp J 2000;16:1142.